Surmodics, Inc. (SRDX)
USD 29.25
(-2.86%)
USD 29.25
(-2.86%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 14.83 Million USD | 25.55% |
| 2022 | 11.81 Million USD | 74.84% |
| 2021 | 6.76 Million USD | 13.31% |
| 2020 | 5.96 Million USD | 32.55% |
| 2019 | 4.5 Million USD | 12.08% |
| 2018 | 4.01 Million USD | 14.22% |
| 2017 | 3.51 Million USD | -1.76% |
| 2016 | 3.57 Million USD | 20.14% |
| 2015 | 2.97 Million USD | 5.75% |
| 2014 | 2.81 Million USD | -15.35% |
| 2013 | 3.32 Million USD | -5.56% |
| 2012 | 3.52 Million USD | -15.08% |
| 2011 | 4.15 Million USD | 36.2% |
| 2010 | 3.04 Million USD | -8.5% |
| 2009 | 3.33 Million USD | 25.61% |
| 2008 | 2.65 Million USD | 6.17% |
| 2007 | 2.49 Million USD | 162.29% |
| 2006 | 952 Thousand USD | -12.74% |
| 2005 | 1.09 Million USD | 4.9% |
| 2004 | 1.04 Million USD | 20.51% |
| 2003 | 863 Thousand USD | 15.68% |
| 2002 | 746 Thousand USD | 3.04% |
| 2001 | 724 Thousand USD | 44.8% |
| 2000 | 500 Thousand USD | 0.0% |
| 1999 | 500 Thousand USD | 25.0% |
| 1998 | 400 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 14.43 Million USD | -2.7% |
| 2024 Q3 | 15.4 Million USD | 0.0% |
| 2024 Q2 | 15.4 Million USD | 6.7% |
| 2023 Q3 | 14.61 Million USD | 6.12% |
| 2023 Q4 | 14.83 Million USD | 1.57% |
| 2023 FY | 14.83 Million USD | 25.55% |
| 2023 Q1 | 12.72 Million USD | 7.66% |
| 2023 Q2 | 13.76 Million USD | 8.2% |
| 2022 Q1 | 8.29 Million USD | 22.63% |
| 2022 Q2 | 9.47 Million USD | 14.25% |
| 2022 Q3 | 10.92 Million USD | 15.36% |
| 2022 Q4 | 11.81 Million USD | 8.17% |
| 2022 FY | 11.81 Million USD | 74.84% |
| 2021 Q1 | 6.26 Million USD | 4.94% |
| 2021 FY | 6.76 Million USD | 13.31% |
| 2021 Q2 | 6.3 Million USD | 0.77% |
| 2021 Q4 | 6.76 Million USD | 7.03% |
| 2021 Q3 | 6.31 Million USD | 0.11% |
| 2020 Q3 | 5.87 Million USD | 2.3% |
| 2020 Q2 | 5.74 Million USD | 15.94% |
| 2020 Q1 | 4.95 Million USD | 10.0% |
| 2020 FY | 5.96 Million USD | 32.55% |
| 2020 Q4 | 5.96 Million USD | 1.6% |
| 2019 Q3 | 4.15 Million USD | -4.46% |
| 2019 FY | 4.5 Million USD | 12.08% |
| 2019 Q2 | 4.34 Million USD | 4.25% |
| 2019 Q1 | 4.16 Million USD | 3.78% |
| 2019 Q4 | 4.5 Million USD | 8.43% |
| 2018 Q2 | 4.04 Million USD | 4.52% |
| 2018 Q4 | 4.01 Million USD | 1.03% |
| 2018 FY | 4.01 Million USD | 14.22% |
| 2018 Q1 | 3.87 Million USD | 10.1% |
| 2018 Q3 | 3.97 Million USD | -1.75% |
| 2017 Q3 | 3.5 Million USD | 4.72% |
| 2017 FY | 3.51 Million USD | -1.76% |
| 2017 Q4 | 3.51 Million USD | 0.31% |
| 2017 Q2 | 3.34 Million USD | -3.6% |
| 2017 Q1 | 3.47 Million USD | -2.99% |
| 2016 Q3 | 3.34 Million USD | 0.3% |
| 2016 FY | 3.57 Million USD | 20.14% |
| 2016 Q2 | 3.33 Million USD | 1.03% |
| 2016 Q1 | 3.3 Million USD | 10.81% |
| 2016 Q4 | 3.57 Million USD | 7.0% |
| 2015 Q1 | 2.82 Million USD | 0.43% |
| 2015 Q2 | 3.19 Million USD | 12.94% |
| 2015 Q4 | 2.97 Million USD | -14.0% |
| 2015 Q3 | 3.46 Million USD | 8.42% |
| 2015 FY | 2.97 Million USD | 5.75% |
| 2014 Q4 | 2.81 Million USD | -2.86% |
| 2014 Q1 | 2.83 Million USD | -14.9% |
| 2014 Q2 | 2.75 Million USD | -2.61% |
| 2014 Q3 | 2.9 Million USD | 5.15% |
| 2014 FY | 2.81 Million USD | -15.35% |
| 2013 Q4 | 3.32 Million USD | 3.68% |
| 2013 Q3 | 3.21 Million USD | -4.58% |
| 2013 Q1 | 3.22 Million USD | -8.57% |
| 2013 Q2 | 3.36 Million USD | 4.41% |
| 2013 FY | 3.32 Million USD | -5.56% |
| 2012 Q1 | 2.97 Million USD | -28.39% |
| 2012 FY | 3.52 Million USD | -15.08% |
| 2012 Q3 | 3.26 Million USD | -10.97% |
| 2012 Q2 | 3.66 Million USD | 23.32% |
| 2012 Q4 | 3.52 Million USD | 8.0% |
| 2011 FY | 4.15 Million USD | 36.2% |
| 2011 Q1 | 3.11 Million USD | 2.1% |
| 2011 Q2 | 3.08 Million USD | -0.87% |
| 2011 Q3 | 3.73 Million USD | 21.11% |
| 2011 Q4 | 4.15 Million USD | 11.11% |
| 2010 Q4 | 3.04 Million USD | -13.09% |
| 2010 Q3 | 3.5 Million USD | 5.86% |
| 2010 Q2 | 3.31 Million USD | -3.8% |
| 2010 Q1 | 3.44 Million USD | 3.39% |
| 2010 FY | 3.04 Million USD | -8.5% |
| 2009 Q3 | 3.1 Million USD | 0.13% |
| 2009 FY | 3.33 Million USD | 25.61% |
| 2009 Q1 | 2.69 Million USD | 1.58% |
| 2009 Q2 | 3.1 Million USD | 15.3% |
| 2009 Q4 | 3.33 Million USD | 7.11% |
| 2008 Q2 | 2.59 Million USD | 7.78% |
| 2008 FY | 2.65 Million USD | 6.17% |
| 2008 Q4 | 2.65 Million USD | -10.83% |
| 2008 Q3 | 2.97 Million USD | 14.74% |
| 2008 Q1 | 2.4 Million USD | -3.72% |
| 2007 Q2 | 990 Thousand USD | 6.11% |
| 2007 Q4 | 2.49 Million USD | 98.33% |
| 2007 Q1 | 933 Thousand USD | -2.0% |
| 2007 Q3 | 1.25 Million USD | 27.17% |
| 2007 FY | 2.49 Million USD | 162.29% |
| 2006 Q3 | 1.11 Million USD | -2.53% |
| 2006 Q4 | 952 Thousand USD | -14.62% |
| 2006 Q2 | 1.14 Million USD | -0.78% |
| 2006 Q1 | 1.15 Million USD | 5.68% |
| 2006 FY | 952 Thousand USD | -12.74% |
| 2005 Q2 | 992 Thousand USD | -10.23% |
| 2005 Q1 | 1.1 Million USD | 6.25% |
| 2005 FY | 1.09 Million USD | 4.9% |
| 2005 Q4 | 1.09 Million USD | 6.03% |
| 2005 Q3 | 1.02 Million USD | 3.73% |
| 2004 Q3 | 1.01 Million USD | -3.16% |
| 2004 FY | 1.04 Million USD | 20.51% |
| 2004 Q4 | 1.04 Million USD | 2.87% |
| 2004 Q1 | 854 Thousand USD | -1.04% |
| 2004 Q2 | 1.04 Million USD | 22.25% |
| 2003 FY | 863 Thousand USD | 15.68% |
| 2003 Q3 | 831 Thousand USD | 14.15% |
| 2003 Q2 | 728 Thousand USD | -10.34% |
| 2003 Q1 | 812 Thousand USD | 8.85% |
| 2003 Q4 | 863 Thousand USD | 3.85% |
| 2002 Q2 | 739 Thousand USD | 4.08% |
| 2002 Q1 | 710 Thousand USD | -1.93% |
| 2002 Q4 | 746 Thousand USD | 2.05% |
| 2002 Q3 | 731 Thousand USD | -1.08% |
| 2002 FY | 746 Thousand USD | 3.04% |
| 2001 Q3 | 761 Thousand USD | 10.29% |
| 2001 Q4 | 724 Thousand USD | -4.86% |
| 2001 FY | 724 Thousand USD | 44.8% |
| 2001 Q2 | 690 Thousand USD | 20.42% |
| 2001 Q1 | 573 Thousand USD | 14.6% |
| 2000 Q4 | 500 Thousand USD | -11.03% |
| 2000 Q2 | 511 Thousand USD | 2.2% |
| 2000 FY | 500 Thousand USD | 0.0% |
| 2000 Q1 | 500 Thousand USD | 0.0% |
| 2000 Q3 | 562 Thousand USD | 9.98% |
| 1999 Q4 | 500 Thousand USD | 0.0% |
| 1999 Q1 | 400 Thousand USD | 0.0% |
| 1999 Q3 | 500 Thousand USD | 25.0% |
| 1999 Q2 | 400 Thousand USD | 0.0% |
| 1999 FY | 500 Thousand USD | 25.0% |
| 1998 Q3 | 300 Thousand USD | 0.0% |
| 1998 FY | 400 Thousand USD | 0.0% |
| 1998 Q2 | 300 Thousand USD | 0.0% |
| 1998 Q4 | 400 Thousand USD | 33.33% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 3.31 Million USD | -348.308% |
| BrainsWay Ltd. | 3.71 Million USD | -299.22% |
| Cerus Corporation | 39.86 Million USD | 62.78% |
| Envoy Medical, Inc. | 1.4 Million USD | -956.909% |
| electroCore, Inc. | 2.16 Million USD | -586.991% |
| Helius Medical Technologies, Inc. | 457 Thousand USD | -3147.046% |
| IceCure Medical Ltd | 2.27 Million USD | -552.264% |
| Inogen, Inc. | 21.84 Million USD | 32.056% |
| OrthoPediatrics Corp. | 105.85 Million USD | 85.981% |
| Lucid Diagnostics Inc. | 278 Thousand USD | -5237.77% |
| Monogram Orthopaedics, Inc. | 1.00 USD | -1483899900.0% |
| MaxCyte, Inc. | 12.22 Million USD | -21.343% |
| NeuroOne Medical Technologies Corporation | 1.72 Million USD | -759.392% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -9386.639% |
| Orthofix Medical Inc. | 222.16 Million USD | 93.321% |
| PAVmed Inc | 1.01 Million USD | -1359.097% |
| Rapid Micro Biosystems, Inc. | 19.96 Million USD | 25.66% |
| RxSight, Inc. | 17.42 Million USD | 14.821% |
| Sight Sciences, Inc. | 7.84 Million USD | -89.056% |
| SI-BONE, Inc. | 20.24 Million USD | 26.717% |
| TELA Bio, Inc. | 13.16 Million USD | -12.741% |
| Treace Medical Concepts, Inc. | 29.24 Million USD | 49.26% |
| Vivos Therapeutics, Inc. | 1.00 USD | -1483899900.0% |
| Acutus Medical, Inc. | 4.27 Million USD | -246.868% |
| Talis Biomedical Corporation | - USD | -Infinity% |
| Spectral AI, Inc. | 230 Thousand USD | -6351.739% |
| Nano-X Imaging Ltd. | 2.35 Million USD | -529.839% |
| CVRx, Inc. | 10.98 Million USD | -35.109% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 390.07 Thousand USD | -3704.13% |
| Bioventus Inc. | 91.33 Million USD | 83.753% |
| Venus Concept Inc. | 28.67 Million USD | 48.253% |
| TriSalus Life Sciences, Inc. | 2.54 Million USD | -483.065% |
| LivaNova PLC | 147.88 Million USD | 89.966% |
| 908 Devices Inc. | 14.93 Million USD | 0.663% |
| Alphatec Holdings, Inc. | 136.84 Million USD | 89.156% |
| Nemaura Medical Inc. | 1.75 Million USD | -745.598% |
| NeuroPace, Inc. | 11.21 Million USD | -32.326% |
| LENSAR, Inc. | 15.68 Million USD | 5.418% |
| Apyx Medical Corporation | 9.92 Million USD | -49.541% |
| Cutera, Inc. | 72.1 Million USD | 79.419% |
| STRATA Skin Sciences, Inc. | 2.67 Million USD | -455.144% |
| BioSig Technologies, Inc. | -103 Thousand USD | 14506.796% |
| Anika Therapeutics, Inc. | 46.38 Million USD | 68.01% |
| ClearPoint Neuro, Inc. | 7.91 Million USD | -87.574% |
| Integra LifeSciences Holdings Corporation | 389.6 Million USD | 96.191% |
| Axonics, Inc. | 79.94 Million USD | 81.437% |
| Outset Medical, Inc. | 49.21 Million USD | 69.849% |
| IRIDEX Corporation | 9.9 Million USD | -49.798% |
| PROCEPT BioRobotics Corporation | 39.75 Million USD | 62.675% |
| IRadimed Corporation | 12.82 Million USD | -15.738% |
| Tivic Health Systems, Inc. | 756 Thousand USD | -1862.831% |
| INVO Bioscience, Inc. | 264.5 Thousand USD | -5510.059% |
| Telesis Bio, Inc. | 4.02 Million USD | -268.671% |
| Viemed Healthcare, Inc. | 4.6 Million USD | -222.284% |
| Varex Imaging Corporation | 277.5 Million USD | 94.653% |
| Quipt Home Medical Corp. | 18.32 Million USD | 19.026% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 16.74 Million USD | 11.372% |
| Dynatronics Corporation | 5.59 Million USD | -165.268% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 3.74 Million USD | -296.659% |
| Semler Scientific, Inc. | 445 Thousand USD | -3234.607% |
| InMode Ltd. | 45.09 Million USD | 67.094% |
| Bruker Corporation | 968.3 Million USD | 98.468% |
| Cytosorbents Corporation | 3.68 Million USD | -303.22% |
| DexCom, Inc. | 559.6 Million USD | 97.348% |
| Align Technology, Inc. | 296.9 Million USD | 95.002% |
| Viveve Medical, Inc. | 1.47 Million USD | -908.084% |
| ZimVie Inc. | 79.6 Million USD | 81.358% |
| Movano Inc. | 1.51 Million USD | -880.767% |
| Cytek Biosciences, Inc. | 60.87 Million USD | 75.625% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -9386.639% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 157.93 Million USD | 90.604% |
| Profound Medical Corp. | 6.95 Million USD | -113.411% |
| Insulet Corporation | 402.6 Million USD | 96.314% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| iCAD, Inc. | 917 Thousand USD | -1518.212% |
| Nuwellis, Inc. | 1.99 Million USD | -643.065% |
| Biotricity, Inc. | 1.87 Million USD | -689.56% |
| iRhythm Technologies, Inc. | 13.97 Million USD | -6.198% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 2.1 Million USD | -604.606% |
| PAVmed Inc. | 1.01 Million USD | -1359.097% |
| BIOLASE, Inc. | 11.43 Million USD | -29.791% |
| Beyond Air, Inc. | 2.12 Million USD | -597.649% |
| FONAR Corporation | 2.71 Million USD | -446.467% |
| AxoGen, Inc. | 23.02 Million USD | 35.539% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 22.52 Million USD | 34.128% |
| Inari Medical, Inc. | 42.9 Million USD | 65.41% |
| UFP Technologies, Inc. | 70.19 Million USD | 78.859% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 629.17 Thousand USD | -2258.47% |
| Tenon Medical, Inc. | 554 Thousand USD | -2578.52% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 1.66 Million USD | -791.378% |
| AdaptHealth Corp. | 113.64 Million USD | 86.942% |
| Sintx Technologies, Inc. | 888 Thousand USD | -1571.059% |
| NanoVibronix, Inc. | 2.73 Million USD | -443.155% |
| Quanterix Corporation | 22.36 Million USD | 33.651% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 14.84 Million USD | 0.054% |
| Pacific Biosciences of California, Inc. | 56.67 Million USD | 73.818% |
| TransMedics Group, Inc. | 44.23 Million USD | 66.454% |
| ReWalk Robotics Ltd. | 5.65 Million USD | -162.498% |
| NeuroMetrix, Inc. | 1.55 Million USD | -851.567% |
| Hyperfine, Inc. | 6.58 Million USD | -125.448% |
| Establishment Labs Holdings Inc. | 79.93 Million USD | 81.437% |
| Biomerica, Inc. | 2.37 Million USD | -524.537% |
| Bone Biologics Corporation | -328.84 Thousand USD | 4612.474% |
| AVITA Medical, Inc. | 3.12 Million USD | -375.394% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 29.87 Million USD | 50.331% |